CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TheraPanacea is developing the ART-AI platform, the first fully automated treatment planning system for MRI-guided radiotherapy. This innovative platform uses advanced artificial intelligence and imaging techniques to optimize treatment plans in real-time, aiming to enhance patient outcomes and reduce side effects asso…
Current radiotherapy is fully reliant on semi-automatic treatment planning systems (TPS) that depend on highly toxic CT scans and human clinical expertise for creating a treatment plan.
As a result, the procedure is inefficient and inefficacious resulting in poor treatment outcome and severe side effects.
In recent years, there has been an emergence of the concept of MRI-guided radiotherapy, wherein non-toxic and high resolution MRI images are used to guide treatment planning.
As a result, sever…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
